Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis

Justin Loloi, Ian Gilchrist

Research output: Contribution to journalEditorial

Abstract

Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

Original languageEnglish (US)
Pages (from-to)16-17
Number of pages2
JournalCatheterization and Cardiovascular Interventions
Volume92
Issue number1
DOIs
StatePublished - Jul 1 2018

Fingerprint

Hemophilia A
Thrombosis
Hemorrhage
Inborn Genetic Diseases
Drug-Eluting Stents
Standard of Care
Cardiac Catheterization
Therapeutics

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{65c8b3b288874aff9f5906b5e45f7eeb,
title = "Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis",
abstract = "Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.",
author = "Justin Loloi and Ian Gilchrist",
year = "2018",
month = "7",
day = "1",
doi = "10.1002/ccd.27701",
language = "English (US)",
volume = "92",
pages = "16--17",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Hemophilia in the cath lab : Balancing the need to clot with the treatment of thrombosis. / Loloi, Justin; Gilchrist, Ian.

In: Catheterization and Cardiovascular Interventions, Vol. 92, No. 1, 01.07.2018, p. 16-17.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Hemophilia in the cath lab

T2 - Balancing the need to clot with the treatment of thrombosis

AU - Loloi, Justin

AU - Gilchrist, Ian

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

AB - Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.

UR - http://www.scopus.com/inward/record.url?scp=85051079951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051079951&partnerID=8YFLogxK

U2 - 10.1002/ccd.27701

DO - 10.1002/ccd.27701

M3 - Editorial

C2 - 30917221

AN - SCOPUS:85051079951

VL - 92

SP - 16

EP - 17

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 1

ER -